Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2025-12-25 @ 4:41 PM
NCT ID:
NCT04579757
Group ID:
EG003
Title:
Dose Expansion Phase: Cohort B1: Thoracic NETs
Description:
Patients with thoracic NET who had progressive, locally advanced or metastatic, low-to-intermediate grade (Grade 1 or Grade 2), well-differentiated NETs that progressed on at least 1 line of standard therapy received surufatinib 300 mg orally QD in combination with tislelizumab 200 mg IV infusion Q3W until PD, unacceptable toxicity, withdrawal of consent, new anticancer therapy, lost to follow-up, or death.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
10
Other Number Affected:
10
Other Number At Risk:
10
Study:
NCT04579757
Results Section:
NCT04579757
Adverse Events Module:
NCT04579757